Gabelli Healthcare & WellnessRx (GRX) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $10.09, +1.82% vs the prior close of $9.91.
- Volume 40.64K shares, 1.9x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
GRX rises 1.8% to $10.09, a 1-month high on 1.9x normal volume. Closed at $10.09, +1.82% vs the prior close of $9.91. Day range $9.96–$10.19, opened at $9.95.
GRX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — GRX rises 1.8% to $10.09, a 1-month high on 1.9x normal volume
- Closed at $10.09, +1.82% vs the prior close of $9.91. Day range $9.96–$10.19, opened at $9.95.
- Volume was 40.64K shares, 1.9x its 50-day average of 21.25K — unusually heavy trading.
- Price is +2.8% vs its 50-day average ($9.82) and +6.2% vs its 200-day average ($9.50).
- 52-week range $8.80–$10.20; today's close sits at 92% of that range, 1.1% below the 52-week high.
Oct 15, 2026 — GRX rises 2.4% to $9.91, a 1-month high
- Closed at $9.91, +2.38% vs the prior close of $9.68. Day range $9.68–$9.92, opened at $9.73.
- Volume was 18.00K shares, 0.9x its 50-day average of 21.12K.
- Price is +1.0% vs its 50-day average ($9.81) and +4.4% vs its 200-day average ($9.50).
- 52-week range $8.80–$10.20; today's close sits at 79% of that range, 2.8% below the 52-week high.
Oct 14, 2026 — GRX ends flat (+0.0%) to $9.68
- Closed at $9.68, +0.00% vs the prior close of $9.68. Day range $9.60–$9.71, opened at $9.66.
- Volume was 5.20K shares, 0.2x its 50-day average of 21.37K — lighter than usual.
- Price is -1.3% vs its 50-day average ($9.81) and +2.0% vs its 200-day average ($9.49).
- 52-week range $8.80–$10.20; today's close sits at 63% of that range, 5.1% below the 52-week high.
Oct 13, 2026 — GRX rises 0.7% to $9.68
- Closed at $9.68, +0.73% vs the prior close of $9.61. Day range $9.62–$9.68, opened at $9.65.
- Volume was 4.40K shares, 0.2x its 50-day average of 21.64K — lighter than usual.
- Price is -1.3% vs its 50-day average ($9.81) and +2.0% vs its 200-day average ($9.49).
- 52-week range $8.80–$10.20; today's close sits at 63% of that range, 5.1% below the 52-week high.
Oct 12, 2026 — GRX ends flat (-0.2%) to $9.61
- Closed at $9.61, -0.21% vs the prior close of $9.63. Day range $9.57–$9.64, opened at $9.60.
- Volume was 2.90K shares, 0.1x its 50-day average of 21.79K — lighter than usual.
- Price is -2.0% vs its 50-day average ($9.81) and +1.2% vs its 200-day average ($9.49).
- 52-week range $8.80–$10.20; today's close sits at 58% of that range, 5.8% below the 52-week high.
Oct 9, 2026 — GRX rises 0.3% to $9.63
- Closed at $9.63, +0.31% vs the prior close of $9.60. Day range $9.55–$9.64, opened at $9.55.
- Volume was 9.80K shares, 0.4x its 50-day average of 22.10K — lighter than usual.
- Price is -1.8% vs its 50-day average ($9.81) and +1.4% vs its 200-day average ($9.49).
- 52-week range $8.80–$10.20; today's close sits at 59% of that range, 5.6% below the 52-week high.
Oct 8, 2026 — GRX rises 1.9% to $9.60 on 1.8x normal volume
- Closed at $9.60, +1.91% vs the prior close of $9.42. Day range $9.36–$9.65, opened at $9.40.
- Volume was 39.30K shares, 1.8x its 50-day average of 21.71K — unusually heavy trading.
- Price is -2.2% vs its 50-day average ($9.81) and +1.1% vs its 200-day average ($9.49).
- 52-week range $8.80–$10.20; today's close sits at 57% of that range, 5.9% below the 52-week high.
Oct 7, 2026 — GRX ends flat (+0.0%) to $9.42
- Closed at $9.42, +0.00% vs the prior close of $9.42. Day range $9.41–$9.46, opened at $9.45.
- Volume was 16.80K shares, 0.8x its 50-day average of 21.89K.
- Price is -4.1% vs its 50-day average ($9.82) and -0.8% vs its 200-day average ($9.49).
- 52-week range $8.80–$10.20; today's close sits at 44% of that range, 7.6% below the 52-week high.
Oct 6, 2026 — GRX rises 0.3% to $9.42
- Closed at $9.42, +0.32% vs the prior close of $9.39. Day range $9.33–$9.49, opened at $9.33.
- Volume was 12.40K shares, 0.6x its 50-day average of 21.88K — lighter than usual.
- Price is -4.1% vs its 50-day average ($9.83) and -0.8% vs its 200-day average ($9.49).
- 52-week range $8.80–$10.20; today's close sits at 44% of that range, 7.6% below the 52-week high.
Oct 5, 2026 — GRX ends flat (+0.1%) to $9.39
- Closed at $9.39, +0.11% vs the prior close of $9.38. Day range $9.28–$9.40, opened at $9.33.
- Volume was 7.10K shares, 0.3x its 50-day average of 21.93K — lighter than usual.
- Price is -4.5% vs its 50-day average ($9.83) and -1.1% vs its 200-day average ($9.49).
- 52-week range $8.80–$10.20; today's close sits at 42% of that range, 7.9% below the 52-week high.
Oct 2, 2026 — GRX dips 0.4% to $9.38, a 3-month low, 6 down days in a row
- Closed at $9.38, -0.42% vs the prior close of $9.42. Day range $9.35–$9.59, opened at $9.42.
- Volume was 7.20K shares, 0.3x its 50-day average of 22.17K — lighter than usual.
- Price is -4.6% vs its 50-day average ($9.83) and -1.2% vs its 200-day average ($9.49).
- 52-week range $8.80–$10.20; today's close sits at 41% of that range, 8.0% below the 52-week high.
- That makes 6 straight losses.
GRX latest news & SEC filings
Every SEC filing by or about GRX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Saba Capital Management, L.P. bought 400 shares at $9.40 (≈$3.76K) on Oct 8, 2026; now holds 2,172,341
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Saba Capital Management, L.P. bought 2,955 shares at $9.43 (≈$27.87K) on Oct 7, 2026; now holds 2,171,941
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Saba Capital Management, L.P. bought 4,439 shares at $9.41 (≈$41.77K) on Oct 6, 2026; now holds 2,168,986
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Saba Capital Management, L.P. bought 1,775 shares at $9.38 (≈$16.65K) on Oct 5, 2026; now holds 2,164,547
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Saba Capital Management, L.P. bought 5,720 shares at $9.41 (≈$53.83K) on Oct 1, 2026; now holds 2,162,272
- Saba Capital Management, L.P. bought 500 shares at $9.35 (≈$4.67K) on Oct 2, 2026; now holds 2,162,772
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Saba Capital Management, L.P. bought 519 shares at $9.52 (≈$4.94K) on Sep 30, 2026; now holds 2,156,552
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 31, 2026 · Form NPORT-P — NPORT-P filing
NPORT-P filing
Aug 28, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 19, 2026 · Form N-PX — Annual proxy voting record
Annual proxy voting record
Things to know before you trade GRX
- How much it moves: over the last 20 sessions the average daily move was 0.73% (largest 2.4%). That is a relatively calm stock.
- Liquidity: about 17.96K shares (≈$181.19K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $10.09 vs a range of $8.80–$10.20 (92% of the range).
- Dividends: last ex-dividend date Sep 16, 2026 ($0.17/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Capital Management, L.P. Saba bought 400 shares on Sep 11, 2026.
- Latest filings: 8-K May 7, 2026; 8-K Dec 9, 2010; 8-K Sep 21, 2010.
- Listing: NYSE · industry: —.
GRX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 9.95 | 10.19 | 9.96 | 10.09 | 40.64K |
| Oct 15, 2026 | 9.73 | 9.92 | 9.68 | 9.91 | 18.00K |
| Oct 14, 2026 | 9.66 | 9.71 | 9.60 | 9.68 | 5.20K |
| Oct 13, 2026 | 9.65 | 9.68 | 9.62 | 9.68 | 4.40K |
| Oct 12, 2026 | 9.60 | 9.64 | 9.57 | 9.61 | 2.90K |
| Oct 9, 2026 | 9.55 | 9.64 | 9.55 | 9.63 | 9.80K |
| Oct 8, 2026 | 9.40 | 9.65 | 9.36 | 9.60 | 39.30K |
| Oct 7, 2026 | 9.45 | 9.46 | 9.41 | 9.42 | 16.80K |
| Oct 6, 2026 | 9.33 | 9.49 | 9.33 | 9.42 | 12.40K |
| Oct 5, 2026 | 9.33 | 9.40 | 9.28 | 9.39 | 7.10K |
| Oct 2, 2026 | 9.42 | 9.59 | 9.35 | 9.38 | 7.20K |
| Oct 1, 2026 | 9.51 | 9.54 | 9.33 | 9.42 | 24.20K |
| Sep 30, 2026 | 9.61 | 9.61 | 9.51 | 9.51 | 11.50K |
| Sep 29, 2026 | 9.59 | 9.64 | 9.56 | 9.57 | 6.30K |
| Sep 28, 2026 | 9.66 | 9.69 | 9.58 | 9.61 | 7.70K |
| Sep 25, 2026 | 9.86 | 9.86 | 9.64 | 9.67 | 22.80K |
| Sep 24, 2026 | 9.77 | 9.90 | 9.72 | 9.83 | 19.80K |
| Sep 23, 2026 | 9.80 | 9.88 | 9.75 | 9.80 | 61.10K |
| Sep 22, 2026 | 9.68 | 9.75 | 9.63 | 9.72 | 24.60K |
| Sep 21, 2026 | 9.61 | 9.65 | 9.61 | 9.64 | 17.40K |
About Gabelli Healthcare & WellnessRx
Gabelli Healthcare & WellnessRx (GRX) is listed on the NYSE and classified by the SEC under “—”. Its business address is in RYE, NY. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1391437.
GRX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Mario J Gabelli | Control Person of Adviser | Jan 14, 2026 |
| Anthonie C Vanekris | Director | Dec 2, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| J Christopher Jackson | Secretary | Aug 17, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 11, 2026 | Capital Management, L.P. Saba | Buy | 400 | $9.71 |
| Sep 11, 2026 | Capital Management, L.P. Saba | Buy | 400 | $9.71 |
| Sep 11, 2026 | Capital Management, L.P. Saba | Buy | 400 | $9.71 |
| Sep 11, 2026 | Capital Management, L.P. Saba | Buy | 400 | $9.71 |
| Sep 3, 2026 | Capital Management, L.P. Saba | Buy | 500 | $10.08 |
| Sep 3, 2026 | Capital Management, L.P. Saba | Buy | 500 | $10.08 |
| Sep 3, 2026 | Capital Management, L.P. Saba | Buy | 500 | $10.08 |
| Sep 3, 2026 | Capital Management, L.P. Saba | Buy | 500 | $10.08 |
| Aug 27, 2026 | Capital Management, L.P. Saba | Buy | 4,340 | $10.05 |
| Aug 27, 2026 | Capital Management, L.P. Saba | Buy | 4,340 | $10.05 |
| Aug 27, 2026 | Capital Management, L.P. Saba | Buy | 4,340 | $10.05 |
| Aug 27, 2026 | Capital Management, L.P. Saba | Buy | 4,340 | $10.05 |
| Aug 21, 2026 | Capital Management, L.P. Saba | Buy | 7,087 | $10.13 |
| Aug 21, 2026 | Capital Management, L.P. Saba | Buy | 7,087 | $10.13 |
| Aug 21, 2026 | Capital Management, L.P. Saba | Buy | 7,087 | $10.13 |
GRX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
GRX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on GRX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.